Investigational Site Number :3920001

Sapporo, Hokkaido 065-0033

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Colitis Ulcerative, Congenital Cystic Kidney Disease, Non-small Cell Lung Cancer, Non-squamous Non-small Cell Lung Cancer, Pleural Mesothelioma

Studies at this site

• A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab)) — Running, not enrolling
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) — Stopped early
• Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat — Stopped early
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA — Stopped early